Similar articles

• The epidemiology of NSAID associated gastrointestinal disease.

  Wolfe F. Wolfe F. Eur J Rheumatol Inflamm. 1991;11(3):12-28. Eur J Rheumatol Inflamm. 1991. PMID: 1365476 Review.
• [Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].

  Florent C, Desaint B. Florent C, et al. Gastroenterol Clin Biol. 1989 Mar;13(3):235-8. Gastroenterol Clin Biol. 1989. PMID: 2731675 French. No abstract available.
• [Non-steroid anti-inflammatory agents and digestive tract lesions].

  Lanas Arbeloa AI, Hirschowitz BI. Lanas Arbeloa AI, et al. Rev Esp Enferm Dig. 1993 Nov;84(5):326-35. Rev Esp Enferm Dig. 1993. PMID: 8305260 Review. Spanish. No abstract available.
• Peptic ulcer, nonsteroid anti-inflammatory drugs and the rheumatic diseases.

  Sladen G. Sladen G. Br J Rheumatol. 1986 Nov;25(4):330-2. doi: 10.1093/rheumatology/25.4.330. Br J Rheumatol. 1986. PMID: 3535982 Clinical Trial. No abstract available.
• Selective COX-2 inhibitors: a promise unfulfilled?

  Henry D, McGettigan P. Henry D, et al. Gastroenterology. 2007 Feb;132(2):790-4. doi: 10.1053/j.gastro.2007.01.017. Gastroenterology. 2007. PMID: 17261306 No abstract available.